# Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults

> **NCT00078559** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Wisconsin, Madison** · enrollment: 10 (actual)

## Conditions studied

- Kidney Transplantation
- Kidney Disease

## Interventions

- **DRUG:** Alemtuzumab
- **DRUG:** Sirolimus
- **DRUG:** Tacrolimus
- **PROCEDURE:** Kidney transplant
- **DRUG:** Methylprednisolone (or equivalent)
- **DRUG:** Acetaminophen
- **DRUG:** Diphenhydramine
- **DRUG:** Trimethoprim (TMP)/Sulfa (Bactrim, Septra)
- **DRUG:** Valgancyclovir
- **DRUG:** Acyclovir
- **DRUG:** Pentamidine
- **DRUG:** Clotrimazole
- **DRUG:** Nystatin

## Key facts

- **NCT ID:** NCT00078559
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2018-06-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00078559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00078559, "Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00078559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*